Delivery Order SPE2DB22D1202-SPE2DB25FUEP9
Award Date
10/7/24
Potential Completion Date
10/8/24
Potential Value
$2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $1,141.20, is for the delivery of Olmesartan-HCTZ 40-25 mg tablets in quantities of 30. It is a Firm Fixed Price Delivery Order contract with a completion date of November 15, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award is for the delivery order SPE2DX15D3020|SPE2DX24FXHPG, valued at $33,606.60, issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a pharmaceutical distribution company. The award is for the delivery of Olmesartan-HCTZ 40-25 mg tablets in 30-count packages. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical,...
This is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,306.58 firm fixed-price delivery order is for the supply of Olmesartan-HCTZ 40-12.5 mg tablets, with a period of performance through November 13, 2023. This order is part of AmerisourceBergen's large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999,...
This is a delivery order under a Defense Logistics Agency (DLA) Indefinite Delivery Contract (IDC) awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,659.68, is for the delivery of Olmesartan-HCTZ 40-12.5 mg tablets in 30-count packages. This award is not designated as a set-aside contract. The IDC held by AmerisourceBergen with the DLA Troop Support Medical is valued at $999,999,999 and runs through...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The firm fixed price delivery order, valued at $2,707.35, is for the supply of Olmesartan-HCTZ 40-12.5 mg tablets. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA, with a potential value of...
This federal contract award is for the delivery of Olmesartan-HCTZ 40-25 mg tablets in quantities of 30 to the Defense Logistics Agency (DLA) Troop Support Medical. The $2,770.74 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on October 18, 2023 with a completion date of October 19, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,945.39, is for the supply of Olmesartan-HCTZ 40-12.5 mg tablets in 90-count packages. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and the contract is a firm-fixed-price delivery order with a performance period...
This federal contract award to AmerisourceBergen Drug Corp is a delivery order under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 through November 2026. The contract provides for the delivery of 4,563,155,110 units of Olmesartan Medoxomil 40 mg tablets in 90-count bottles, with a ceiling value of $5,059.29 and a completion date of December 21, 2023. The award is not designated as a set-aside contract....
This federal contract award, with ID SPE2DX15D2212/SPE2DX24F4Q6M, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $13,465.51 fixed-price delivery order is for the supply of Olmesartan-HCTZ 40-25 mg tablets in 90-count bottles, with a completion date of December 1, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Olmesartan Medoxomil 40 mg tablets. The contract, valued at $3,391.38, is a firm fixed-price delivery order with a period of performance ending on September 5, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...